Cancer Diagnostics – News and Features

Technology Networks spoke to Nick Ainslie, co-founder of Ausel, to find out more about a saliva-based diagnostic designed to indicate the presence of cancer cells at the earliest stage of development without the need for invasive methods.

Monash University-led research is using maths to predict how new combination therapies can help patients with breast cancer who no longer respond to conventional therapies.

We typically think of a cancerous tumor as a bunch of abnormal cells gone rogue, but the situation is more complicated. This article will explore cell-to-cell communication’s role in cancer development, its influence on metastasis and how research is expanding our knowledge of the disease.

Researchers have developed a machine learning-based classifier, which utilizes metabolic profiles of serum samples, to accurately identify people with ovarian cancer.

An investigation conducted by researchers at Karolinska Institutet has led to a discovery in breast cancer diagnostics and treatments that could reshape screening programs and clinical approaches.

Through molecular twin precision oncology platform, Cedars-Sinai cancer investigators identify biomarkers that outperform standard test and could expand the promise of precision medicine.

In the largest study of its kind, scientists report how combining health data with whole genome sequence (WGS) data in patients with cancer can help doctors provide more tailored care for their patients.

Blood test uses cell-free DNA methylation to quantify tumor burden and distinguish neuroendocrine prostate cancer from prostate adenocarcinoma.

A vaccine has shown the potential to prevent the relapse of KRAS-mutated pancreatic and colorectal cancers in a phase I trial.

The diagnostic, which requires only a simple urine test to read the results, could make lung cancer screening more accessible worldwide.